Sientra to Report Second Quarter 2019 Financial Results on August 8, 2019
July 18 2019 - 4:30PM
Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company,
announced today that it will release financial results for the
second quarter 2019 after the close of trading on Thursday, August
8, 2019. Sientra will host a conference call to discuss financial
results the same day at 4:30 p.m. Eastern Time.
The dial-in numbers are 844-464-3933 for
domestic callers and 765-507-2612 for international callers. The
conference ID is 8084147. A live webcast of the conference
call will be available on the Investor Relations section of the
Company's website at www.sientra.com.
A replay of the call will be available starting
on August 8, 2019 at 7:30 p.m. Eastern Time through August 15, 2019
at 7:30 p.m. Eastern Time. To access the replay, dial
855-859-2056 for domestic callers and 404-537-3406 for
international callers and use the replay conference ID 8084147. A
replay of the webcast will be available on the Investor Relations
section of the Company’s website following the completion of the
call.
About Sientra
Headquartered in Santa Barbara, California,
Sientra is a diversified global medical aesthetics company and a
leading partner to aesthetic physicians. The Company offers a suite
of products designed to make a difference in patients' lives by
enhancing their body image, growing their self-esteem, and
restoring their confidence. Sientra has developed a broad portfolio
of products with technologically differentiated characteristics,
supported by independent laboratory testing and strong clinical
trial outcomes. The Company’s Breast Products Segment
includes its OPUS™ breast implants, the first fifth generation
breast implants approved by the FDA for sale in the United States,
its ground-breaking Allox2® breast tissue expander with patented
dual-port and integral drain technology, and BIOCORNEUM® the
#1 performing, preferred and recommended scar gel of plastic
surgeons(*). The Company’s miraDry Segment comprises its
miraDry® system, which is approved for sale in over 40
international markets, and is the only non-invasive FDA-cleared
device for the permanent reduction of underarm sweat, odor and hair
of all colors.____________________(*) Data on file
Investor Relations
805-679-8885
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Sep 2023 to Sep 2024